Drug Shortage Report for MYLAN-BUDESONIDE AQ
Report ID | 23166 |
Drug Identification Number | 02230648 |
Brand name | MYLAN-BUDESONIDE AQ |
Common or Proper name | BUDESONIDE AQ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 100MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 165 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-04-16 |
Actual start date | 2018-04-16 |
Estimated end date | 2020-01-30 |
Actual end date | 2020-01-20 |
Shortage status | Resolved |
Updated date | 2020-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v112 | 2019-03-28 | French | Compare |
v111 | 2019-03-28 | English | Compare |
v110 | 2019-02-01 | French | Compare |
v109 | 2019-02-01 | English | Compare |
v108 | 2019-01-18 | French | Compare |
v107 | 2019-01-18 | English | Compare |
v106 | 2019-01-15 | French | Compare |
v105 | 2019-01-15 | English | Compare |
v104 | 2018-12-19 | French | Compare |
v103 | 2018-12-19 | English | Compare |
v102 | 2018-11-20 | French | Compare |
v101 | 2018-11-20 | English | Compare |
v100 | 2018-10-09 | French | Compare |
v99 | 2018-10-09 | English | Compare |
v98 | 2018-09-24 | French | Compare |
v97 | 2018-09-24 | English | Compare |
v96 | 2018-09-10 | French | Compare |
v95 | 2018-09-10 | English | Compare |
v94 | 2018-07-09 | French | Compare |
v93 | 2018-07-09 | English | Compare |